A Biomarker for Diagnosing Diabetic Nephropathy Comprising Urinary Glycated Albumin

摘要

The present invention relates to a composition for diagnosis of diabetic nephropathy and a composition for measuring change in blood glucose. The present invention provides reliable diagnostic information for diabetic nephropathy and changes in blood glucose only by non-invasive measurement of glycated albumin in urine. In diabetic nephropathy, the present invention can be usefully used as an effective biomarker for disease progression as well as early diagnosis of diseases by providing information on blood glucose changes as well as damage to renal tubules prior to glomerular damage in diabetic nephropathy. have.